Mayom Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Mayom Biotechnology
Mayom Biotechnology Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 September 2015 (Nine years and five months 20 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajit Singh and Raju Sonavane serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120MH2015PTC268225
- Company No.
268225
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Mayom Biotechnology Private Limited offer?
Mayom Biotechnology Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Protein Powder, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Digestive System Drugs & Medicines, Gastrointestinal Drugs.
Who are the key members and board of directors at Mayom Biotechnology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Singh  | Director | 08-Sep-2015 | Current |
| Raju Sonavane | Director | 14-Aug-2020 | Current |
Financial Performance of Mayom Biotechnology.
Mayom Biotechnology Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mayom Biotechnology?
In 2017, Mayom Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mayom Biotechnology?
Unlock and access historical data on people associated with Mayom Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mayom Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mayom Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
